Medical device containing Y-90 microspheres delivered intratumorally and percutaneously into the pancreas clinical trials

Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

This study investigates a new radiotherapy for advanced pancreatic cancer that can't be surgically removed. It involves a single injection of a radioactive implant directly into the tumour, alongside standard chemotherapy. Researchers will assess safety, effectiveness, and impact on quality of life.